Ethinylestradiol/levonorgestrel - Teva

Drug Profile

Ethinylestradiol/levonorgestrel - Teva

Alternative Names: Lo Seasonale®; Seasonale

Latest Information Update: 06 Mar 2014

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Jones Institute for Reproductive Medicine
  • Developer Barr Laboratories; Jones Institute for Reproductive Medicine; Teva Pharmaceutical Industries
  • Class Alkylated estrogenic steroids; Contraceptives; Hormonal replacements; Norpregnanes; Norpregnatrienes; Small molecules
  • Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Marketed Pregnancy
  • Discontinued Bone disorders

Most Recent Events

  • 28 Feb 2014 Endo Health Solutions and Paladin Labs combine to form Endo International
  • 01 Oct 2013 Warner Chilcott has been acquired and merged into Actavis Inc
  • 30 Oct 2009 Warner Chilcott has acquired the global pharmaceutical business of Procter & Gamble
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top